Which companies overlap with Instituto Nacional de Traumatologia e Ortopedia's portfolio?

Top competitors by shared drug class: Fundación Santiago Dexeus Font, Istituto Ortopedico Rizzoli.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/instituto-nacional-de-traumatologia-e-ortopedia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Instituto Nacional de Traumatologia e Ortopedia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Instituto Nacional de Traumatologia e Ortopedia pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Bone marrow aspirate matrix	Bone marrow aspirate matrix	phase 3	Cell therapy / Regenerative medicine product		Orthopedics / Regenerative Medicine

Therapeutic area mix

Orthopedics / Regenerative Medicine · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Fundación Santiago Dexeus Font · 1 shared drug class
Istituto Ortopedico Rizzoli · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Instituto Nacional de Traumatologia e Ortopedia:

Cite this brief

Drug Landscape (2026). Instituto Nacional de Traumatologia e Ortopedia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/instituto-nacional-de-traumatologia-e-ortopedia. Accessed 2026-05-17.